Gap19: Selective Connexin 43 Hemichannel Blocker in Neuro...
2025-10-21
Gap19 enables targeted modulation of neuroglial and inflammatory pathways by selectively inhibiting Cx43 hemichannels without affecting gap junction channels. Its robust performance in cerebral ischemia, ATP release blockade, and macrophage polarization research sets it apart as a gold-standard tool for translational neuroscience and vascular inflammation studies.